Temporal regulation of rapamycin on memory CTL programming by IL-12

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Li, Xiangdong ^a   Garcia, Karla ^a   Sun, Zhifeng ^a   Xiao, Zhengguo ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; L SELECTIN; RAPAMYCIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; IN VITRO STUDY; INTRACELLULAR SIGNALING; LISTERIA MONOCYTOGENES; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN PURIFICATION; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; DRUG EFFECT; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM;

LISTERIA MONOCYTOGENES; MAMMALIA;

ANIMALS; CELLS, CULTURED; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; INTERLEUKIN-12; L-SELECTIN; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIROLIMUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 80053105723     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025177     Document Type: Article

References (42)

1. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225-234.
2. Masopust D, Vezys V, Marzo AL, Lefrancois L, (2001) Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
3. Wherry EJ, Ahmed R, (2004) Memory CD8 T-cell differentiation during viral infection. J Virol 78: 5535-5545.
4. Kaech SM, Wherry EJ, Ahmed R, (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2: 251-262.
5. Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, et al. (2006) Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 211: 81-92.
6. (2007) HIV vaccine failure prompts Merck to halt trial. Nature 449: 390.
7. Ahmed R, Bevan MJ, Reiner SL, Fearon DT, (2009) The precursors of memory: models and controversies. Nat Rev Immunol 9: 662-668.
8. Jameson SC, Masopust D, (2009) Diversity in T cell memory: an embarrassment of riches. Immunity 31: 859-871.
9. Rutishauser RL, Kaech SM, Generating diversity: transcriptional regulation of effector and memory CD8 T-cell differentiation. Immunol Rev 235: 219-233.
10. Arens R, Schoenberger SP, Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev 235: 190-205.
11. Curtsinger JM, Johnson CM, Mescher MF, (2003) CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol 171: 5165-5171.
12. van Stipdonk MJ, Lemmens EE, Schoenberger SP, (2001) Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2: 423-429.
13. Curtsinger JM, Lins DC, Mescher MF, (2003) Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 197: 1141-1151.
14. Harty JT, Badovinac VP, (2008) Shaping and reshaping CD8+ T-cell memory. Nat Rev Immunol 8: 107-119.
15. Way SS, Havenar-Daughton C, Kolumam GA, Orgun NN, Murali-Krishna K, (2007) IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFN-gamma production by CD8 T cells after Listeria monocytogenes infection. J Immunol 178: 4498-4505.
16. Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF, (2009) Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 182: 2786-2794.
17. Yang Q, Guan KL, (2007) Expanding mTOR signaling. Cell Res 17: 666-681.
18. Wullschleger S, Loewith R, Hall MN, (2006) TOR signaling in growth and metabolism. Cell 124: 471-484.
19. Thomson AW, Turnquist HR, Raimondi G, (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9: 324-337.
20. Engelman JA, (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9: 550-562.
21. Liu P, Cheng H, Roberts TM, Zhao JJ, (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644.
22. Vodenik B, Rovira J, Campistol JM, (2009) Mammalian target of rapamycin and diabetes: what does the current evidence tell us? Transplant Proc 41: S31-38.
23. Weichhart T, Saemann MD, (2009) The multiple facets of mTOR in immunity. Trends Immunol 30: 218-226.
24. Ballou LM, Lin RZ, (2008) Rapamycin and mTOR kinase inhibitors. J Chem Biol 1: 27-36.
25. Kroczynska B, Kaur S, Platanias LC, (2009) Growth suppressive cytokines and the AKT/mTOR pathway. Cytokine 48: 138-143.
26. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, et al. (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.
27. Prlic M, Bevan MJ, (2009) Immunology: A metabolic switch to memory. Nature 460: 41-42.
28. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, et al. (2009) Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460: 103-107.
29. Rao RR, Li Q, Odunsi K, Shrikant PA, (2010) The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32: 67-78.
30. Hogquist K, Jameson S, Heath W, Howard J, Bevan M, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
31. Weichhart T, Costantino G, Poglitsch M, Rosner M, Zeyda M, et al. (2008) The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29: 565-577.
32. Mondino A, Mueller DL, (2007) mTOR at the crossroads of T cell proliferation and tolerance. Semin Immunol 19: 162-172.
33. Colombetti S, Basso V, Mueller DL, Mondino A, (2006) Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J Immunol 176: 2730-2738.
34. Yea SS, Fruman DA, (2011) Cell signaling. New mTOR targets Grb attention. Science 332: 1270-1271.
35. Blattman JN, Antia R, Sourdive DJ, Wang X, Kaech SM, et al. (2002) Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 195: 657-664.
36. Whitmire JK, Benning N, Whitton JL, (2006) Precursor frequency, nonlinear proliferation, and functional maturation of virus-specific CD4+ T cells. J Immunol 176: 3028-3036.
37. Curtsinger JM, Mescher MF, (2010) Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol 22: 333-340.
38. Salmond RJ, Emery J, Okkenhaug K, Zamoyska R, (2009) MAPK, phosphatidylinositol 3-kinase, and mammalian target of rapamycin pathways converge at the level of ribosomal protein S6 phosphorylation to control metabolic signaling in CD8 T cells. J Immunol 183: 7388-7397.
39. Sinclair LV, Finlay D, Feijoo C, Cornish GH, Gray A, et al. (2008) Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 9: 513-521.
40. Kusaba H, Ghosh P, Derin R, Buchholz M, Sasaki C, et al. (2005) Interleukin-12-induced interferon-gamma production by human peripheral blood T cells is regulated by mammalian target of rapamycin (mTOR). J Biol Chem 280: 1037-1043.
41. Berstein G, Abraham RT, (2008) Moving out: mobilizing activated T cells from lymphoid tissues. Nat Immunol 9: 455-457.
42. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K, (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202: 637-650.